what are glp-1 agonists Comparing Ozempic, Wegovy and Other Drugs America's Poison Centers - GLP-1
Description
Yes, with conditions

A physician may need to evaluate persistent vomiting, severe abdominal pain, signs of dehydration, worsening reflux, gallbladder symptoms, low blood sugar risk in patients using diabetes medications, kidney function concerns, unintentional under-eating, rapid weakness or muscle loss, and medication interactions

GLP-1RA Mechanism of Action GLP-1 (glucagon-like peptide-1) is a hormone secreted by the intestinal tract during feeding, which enhances insulin secretion and inhibits glucagon secretion in a glucose concentration-dependent manner, and delays gastric emptying to reduce the amount of food eaten through central appetite suppression

Beneficiaries of government programs, including Medicare, Medicaid, TRICARE, VA, or DOD, are not eligible

Newer GLP-1 formulations delivered weight-loss numbers rivaling those of bariatric surgery, with more than half of semaglutide trial participants losing at least 15% of their body weight over 68 weeks
